+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nasal Spray Market By Type, By Application, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 397 Pages
  • March 2023
  • Region: Global
  • Allied Market Research
  • ID: 5835722
Description Jump to:
The nasal spray market valued for $9.21 Billion in 2021 and is estimated to reach $16.85 Billion by 2031, exhibiting a CAGR of 6.2% from 2022 to 2031.

Nasal sprays are useful for treating nasal allergies, clogged noses, and for effectively delivering allergy medications. Nasal allergies can lead to illnesses including fever, coughing, bad breath, and postnasal drips. Nasal sprays provide various benefits, including effective and painless drug administration, improved patient convenience, and widespread availability. Nasal sprays also function as an alternative to pills and allow for needle-free drug administration. The optimal route is thought to be nasal. After all, the fast and direct administration of the drug through the nose has a significant impact on the patient's respiratory system.

It is estimated that nasal spray market is expected to experience significant market growth during the forecast period owing to the increasing geriatric population suffering from various respiratory disorder, the launch of innovative technologies, a boost in healthcare expenditure, and higher government support. In addition, increase in investment by players in R&D and presence of robust pipeline candidates and rise in expenditure on the development of healthcare infrastructure which further facilitate the growth of the market. However, strict, and extended product approval processes are expected to impede the market growth. In contrast, surge in healthcare investments in public as well as private sectors are anticipated to provide significant growth opportunities for the nasal spray market.

The nasal spray market is segmented based on type, application, distribution channel, and region. Depending on type, the market is classified into steroids, antihistamine, saline solutions, decongestants, and others. Based on application, the market is categorized into allergy rhinitis, sinusitis, nasal polyps, and others. Depending on distribution channel, the market is segregated into hospital pharmacies, drug stores & retail pharmacies, and online providers.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The report provides a comprehensive analysis of the key players that operate in the global nasal spray market. The key companies profiled in the report include Apotex Inc., Aurena Laboratories, Bayer AG, Cipla Ltd, GlaxoSmithKline plc, Leeford Healthcare Limited, Novartis AG, Sunovion Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd, and Viatris Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nasal spray market analysis from 2021 to 2031 to identify the prevailing nasal spray market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the nasal spray market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global nasal spray market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Others
  • Steroid
  • Antihistamine
  • Saline Solution
  • Decongestant

By Application

  • Allergy Rhinitis
  • Sinusitis
  • Nasal Polyps
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Providers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • GlaxoSmithKline plc
  • Sun Pharmaceutical Industries Ltd
  • Aurena Laboratories
  • Bayer AG
  • Sunovion Pharmaceuticals Inc.
  • Leeford Healthcare Limited
  • Viatris Inc.
  • Cipla Ltd
  • Novartis AG
  • Apotex Inc.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of nasal disorders
3.4.1.2. Increasing number of generic nasal spray product development and launches
3.4.1.3. Rise in demand for nasal sprays
3.4.2. Restraints
3.4.2.1. Side effects associated with nasal spray
3.4.3. Opportunities
3.4.3.1. Growth potential of emerging economies
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: NASAL SPRAY MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Steroid
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Antihistamine
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Saline Solution
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Decongestant
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Others
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: NASAL SPRAY MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Allergy Rhinitis
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Sinusitis
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Nasal Polyps
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital Pharmacies
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Drug Stores and Retail Pharmacies
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Online Providers
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: NASAL SPRAY MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by Distribution Channel
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by Distribution Channel
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by Distribution Channel
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by Distribution Channel
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by Distribution Channel
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by Distribution Channel
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by Distribution Channel
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by Distribution Channel
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by Distribution Channel
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by Distribution Channel
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by Distribution Channel
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by Distribution Channel
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by Distribution Channel
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by Distribution Channel
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by Distribution Channel
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by Distribution Channel
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by Distribution Channel
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by Distribution Channel
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by Distribution Channel
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by Distribution Channel
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by Distribution Channel
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by Distribution Channel
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by Distribution Channel
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. GlaxoSmithKline plc
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Novartis AG
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Cipla Ltd
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.4. Bayer AG
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Viatris Inc.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. Sun Pharmaceutical Industries Ltd
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Aurena Laboratories
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Apotex Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Key strategic moves and developments
9.9. Leeford Healthcare Limited
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. Sunovion Pharmaceuticals Inc.
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
List of Tables
TABLE 01. GLOBAL NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 02. NASAL SPRAY MARKET FOR STEROID, BY REGION, 2021-2031 ($MILLION)
TABLE 03. NASAL SPRAY MARKET FOR ANTIHISTAMINE, BY REGION, 2021-2031 ($MILLION)
TABLE 04. NASAL SPRAY MARKET FOR SALINE SOLUTION, BY REGION, 2021-2031 ($MILLION)
TABLE 05. NASAL SPRAY MARKET FOR DECONGESTANT, BY REGION, 2021-2031 ($MILLION)
TABLE 06. NASAL SPRAY MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 07. GLOBAL NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 08. NASAL SPRAY MARKET FOR ALLERGY RHINITIS, BY REGION, 2021-2031 ($MILLION)
TABLE 09. NASAL SPRAY MARKET FOR SINUSITIS, BY REGION, 2021-2031 ($MILLION)
TABLE 10. NASAL SPRAY MARKET FOR NASAL POLYPS, BY REGION, 2021-2031 ($MILLION)
TABLE 11. NASAL SPRAY MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 12. GLOBAL NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 13. NASAL SPRAY MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
TABLE 14. NASAL SPRAY MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
TABLE 15. NASAL SPRAY MARKET FOR ONLINE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. NASAL SPRAY MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 17. NORTH AMERICA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 20. NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. U.S. NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 22. U.S. NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 23. U.S. NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 24. CANADA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 25. CANADA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 26. CANADA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 27. MEXICO NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 28. MEXICO NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 29. MEXICO NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 30. EUROPE NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 31. EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 32. EUROPE NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 33. EUROPE NASAL SPRAY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 34. GERMANY NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 35. GERMANY NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 36. GERMANY NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 37. FRANCE NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 38. FRANCE NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 39. FRANCE NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 40. UK NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 41. UK NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 42. UK NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 43. ITALY NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 44. ITALY NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 45. ITALY NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 46. SPAIN NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 47. SPAIN NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 48. SPAIN NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 49. REST OF EUROPE NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 50. REST OF EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 51. REST OF EUROPE NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 52. ASIA-PACIFIC NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 53. ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 54. ASIA-PACIFIC NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 55. ASIA-PACIFIC NASAL SPRAY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 56. JAPAN NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 57. JAPAN NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 58. JAPAN NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 59. CHINA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 60. CHINA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 61. CHINA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 62. INDIA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 63. INDIA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 64. INDIA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 65. AUSTRALIA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 66. AUSTRALIA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 67. AUSTRALIA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 68. SOUTH KOREA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 69. SOUTH KOREA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. SOUTH KOREA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 74. LAMEA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 75. LAMEA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 76. LAMEA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 77. LAMEA NASAL SPRAY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 78. BRAZIL NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 79. BRAZIL NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 80. BRAZIL NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 81. SAUDI ARABIA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 82. SAUDI ARABIA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 83. SAUDI ARABIA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 84. SOUTH AFRICA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 85. SOUTH AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 86. SOUTH AFRICA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 87. REST OF LAMEA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 88. REST OF LAMEA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 89. REST OF LAMEA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 90. GLAXOSMITHKLINE PLC: KEY EXECUTIVES
TABLE 91. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
TABLE 92. GLAXOSMITHKLINE PLC: PRODUCT SEGMENTS
TABLE 93. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
TABLE 94. NOVARTIS AG: KEY EXECUTIVES
TABLE 95. NOVARTIS AG: COMPANY SNAPSHOT
TABLE 96. NOVARTIS AG: PRODUCT SEGMENTS
TABLE 97. NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 98. CIPLA LTD: KEY EXECUTIVES
TABLE 99. CIPLA LTD: COMPANY SNAPSHOT
TABLE 100. CIPLA LTD: PRODUCT SEGMENTS
TABLE 101. CIPLA LTD: PRODUCT PORTFOLIO
TABLE 102. BAYER AG: KEY EXECUTIVES
TABLE 103. BAYER AG: COMPANY SNAPSHOT
TABLE 104. BAYER AG: PRODUCT SEGMENTS
TABLE 105. BAYER AG: PRODUCT PORTFOLIO
TABLE 106. BAYER AG: KEY STRATEGIES
TABLE 107. VIATRIS INC.: KEY EXECUTIVES
TABLE 108. VIATRIS INC.: COMPANY SNAPSHOT
TABLE 109. VIATRIS INC.: PRODUCT SEGMENTS
TABLE 110. VIATRIS INC.: PRODUCT PORTFOLIO
TABLE 111. SUN PHARMACEUTICAL INDUSTRIES LTD: KEY EXECUTIVES
TABLE 112. SUN PHARMACEUTICAL INDUSTRIES LTD: COMPANY SNAPSHOT
TABLE 113. SUN PHARMACEUTICAL INDUSTRIES LTD: PRODUCT SEGMENTS
TABLE 114. SUN PHARMACEUTICAL INDUSTRIES LTD: PRODUCT PORTFOLIO
TABLE 115. AURENA LABORATORIES: KEY EXECUTIVES
TABLE 116. AURENA LABORATORIES: COMPANY SNAPSHOT
TABLE 117. AURENA LABORATORIES: PRODUCT SEGMENTS
TABLE 118. AURENA LABORATORIES: PRODUCT PORTFOLIO
TABLE 119. APOTEX INC.: KEY EXECUTIVES
TABLE 120. APOTEX INC.: COMPANY SNAPSHOT
TABLE 121. APOTEX INC.: PRODUCT SEGMENTS
TABLE 122. APOTEX INC.: PRODUCT PORTFOLIO
TABLE 123. APOTEX INC.: KEY STRATEGIES
TABLE 124. LEEFORD HEALTHCARE LIMITED: KEY EXECUTIVES
TABLE 125. LEEFORD HEALTHCARE LIMITED: COMPANY SNAPSHOT
TABLE 126. LEEFORD HEALTHCARE LIMITED: PRODUCT SEGMENTS
TABLE 127. LEEFORD HEALTHCARE LIMITED: PRODUCT PORTFOLIO
TABLE 128. SUNOVION PHARMACEUTICALS INC.: KEY EXECUTIVES
TABLE 129. SUNOVION PHARMACEUTICALS INC.: COMPANY SNAPSHOT
TABLE 130. SUNOVION PHARMACEUTICALS INC.: PRODUCT SEGMENTS
TABLE 131. SUNOVION PHARMACEUTICALS INC.: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. NASAL SPRAY MARKET, 2021-2031
FIGURE 02. SEGMENTATION OF NASAL SPRAY MARKET, 2021-2031
FIGURE 03. TOP INVESTMENT POCKETS IN NASAL SPRAY MARKET (2022-2031)
FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
FIGURE 06. HIGH THREAT OF SUBSTITUTES
FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALNASAL SPRAY MARKET
FIGURE 10. NASAL SPRAY MARKET, BY TYPE, 2021(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR STEROID, BY COUNTRY 2021 AND 2031(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR ANTIHISTAMINE, BY COUNTRY 2021 AND 2031(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR SALINE SOLUTION, BY COUNTRY 2021 AND 2031(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR DECONGESTANT, BY COUNTRY 2021 AND 2031(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 16. NASAL SPRAY MARKET, BY APPLICATION, 2021(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR ALLERGY RHINITIS, BY COUNTRY 2021 AND 2031(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR SINUSITIS, BY COUNTRY 2021 AND 2031(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR NASAL POLYPS, BY COUNTRY 2021 AND 2031(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 21. NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY 2021 AND 2031(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY 2021 AND 2031(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR ONLINE PROVIDERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 25. NASAL SPRAY MARKET BY REGION, 2021
FIGURE 26. U.S. NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 27. CANADA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 28. MEXICO NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 29. GERMANY NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 30. FRANCE NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 31. UK NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 32. ITALY NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 33. SPAIN NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 34. REST OF EUROPE NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 35. JAPAN NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 36. CHINA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 37. INDIA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 38. AUSTRALIA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 39. SOUTH KOREA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 40. REST OF ASIA-PACIFIC NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 41. BRAZIL NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 42. SAUDI ARABIA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 43. SOUTH AFRICA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 44. REST OF LAMEA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 49. COMPETITIVE DASHBOARD
FIGURE 50. COMPETITIVE HEATMAP: NASAL SPRAY MARKET
FIGURE 51. TOP PLAYER POSITIONING, 2021
FIGURE 52. GLAXOSMITHKLINE PLC: NET SALES, 2020-2022 ($MILLION)
FIGURE 53. NOVARTIS AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 54. NOVARTIS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 55. NOVARTIS AG: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 56. BAYER AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 57. BAYER AG: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 58. BAYER AG: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 59. VIATRIS INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 60. VIATRIS INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 61. SUN PHARMACEUTICAL INDUSTRIES LTD: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 62. SUN PHARMACEUTICAL INDUSTRIES LTD: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 63. SUNOVION PHARMACEUTICALS INC.: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 64. SUNOVION PHARMACEUTICALS INC.: REVENUE SHARE BY REGION, 2021 (%)

Companies Mentioned

  • GlaxoSmithKline plc
  • Sun Pharmaceutical Industries Ltd
  • Aurena Laboratories
  • Bayer AG
  • Sunovion Pharmaceuticals Inc.
  • Leeford Healthcare Limited
  • Viatris Inc.
  • Cipla Ltd
  • Novartis AG
  • Apotex Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Related Topics

Related Reports

Inhalation and Nasal Spray Generic Drugs: Global Strategic Business Report - Product Image

Inhalation and Nasal Spray Generic Drugs: Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Nasal spray Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Nasal spray Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 121 Pages
  • Global
From
Corticosteroid Nasal Spray Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Corticosteroid Nasal Spray Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 107 Pages
  • Global
From
Global Inhalation And Nasal Spray Generic Drugs Market Analysis & Forecast to 2024-2034 - Product Image

Global Inhalation And Nasal Spray Generic Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Inhalation and Nasal Spray Generic Drugs Global Market Report 2024 - Product Image

Inhalation and Nasal Spray Generic Drugs Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.